Aptorum Group Ltd. (APM)
0.7826
-0.07
(-8.13%)
USD |
NASDAQ |
Feb 13, 16:00
0.77
-0.01
(-1.61%)
After-Hours: 20:00
Aptorum Group EPS Diluted (Quarterly) : -0.086 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.1479 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.6166M |
| Total Expenses (Quarterly) | 0.614M |
| Enterprise Value | -1.762M |
| Earnings Yield | -44.91% |
| Normalized Earnings Yield | -28.97 |